Autopsy report · NCT03188822

Steroid Delivery to the Frontal Sinus Opening With a Bioabsorbable Implant vs. a Bioabsorbable Nasal Dressing

“Study enrollment was too slow to complete the study in a reasonable time”

The sponsor’s own words in the registry.

Life of this trial

• Registered 2 months before it started.
• Ran for about 4 years 2 months before it stopped.
• 9 participants enrolled.
• Results were posted on the registry 1 month after it ended.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

University of Rochester

Sponsor type

University, hospital or other

Conditions

Chronic Rhinosinusitis (Diagnosis)

Interventions

Bioabsorbable steroid releasing sinus implant; Bioabsorbable nasal dressing impregnated with steroid

Participants

9

Sites

1

Countries

United States

Trials that died the same way

• Study in Adult Subjects Undergoing Posterolateral Thoracotomy
  “Slow study enrollment” (87% match in meaning)
• Concurrent Nab-P/Carboplatin and Thoracic Radiotherapy in Squamous Cell Lung Cancer
  “The study was halted because enrollment was too slow” (85% match in meaning)
• Dabrafenib, Trametinib, and Spartalizumab for the Treatment of BRAF V600E or V600K Mutation Positive Stage IIIB/C/D Melanoma
  “Study stopped due to slow enrollment” (85% match in meaning)
• T2 FSL2 Weight Loss
  “Slow enrollment and Study no longer required” (85% match in meaning)
• Circumferential Compression STITCH Repairs of Complex and Horizontal Cleavage Meniscal Tears
  “Slow enrollment resulted in the decision to prematurely terminate the study” (83% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.